Introduction
Bronchial carcinoma is the second most commonly diagnosed cancer, and is currently the number one cause of cancer death in the UK. Smoking is the major risk factor for the development of bronchial carcinoma and trends in smoking habits are reflected in incidence rates. Poor survival is due in part, to late development of symptoms, and a tendency for the presence of metastatic spread at presentation. This study aims to evaluate the efficacy of current treatments and whether or not prevention strategies should play a more prominent role in the future.